Paolo Casali

Paolo Casali

Department of Microbiology, University of Texas Long School of Medicine at San Antonio

Affiliated withUniversity of Texas Long School of Medicine at San Antonio

Research Area

Biography

Paolo Casali has not added Biography.
If you are Paolo Casali and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Publication title

Cited by 2

2017

Other Publications

Article
Year
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?

Translational oncology| PubMed ID: 19043528

2008
A new journal... on spindle cells.

Clinical sarcoma research| PubMed ID: 22613678

2011
Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 16234529

2005
2006
2006
2006
2006
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 16624552

2006
2006
DNA repair in antibody somatic hypermutation.

Trends in immunology| PubMed ID: 16737852

2006
2006
2006
2006
2007
Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17145809

2006
2007
2007
DNA replication to aid somatic hypermutation.

Advances in experimental medicine and biology| PubMed ID: 17338180

2007
2007
2007
c-Kit/PDGFRA gene status alterations possibly related to primary imatinib resistance in gastrointestinal stromal tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 17438095

2007
2007
2007
Chordoma.

Current opinion in oncology| PubMed ID: 17545801

2007
2007
2007
2007
2007
Combined modalities approach for localized adult extremity soft-tissue sarcoma.

Expert review of anticancer therapy| PubMed ID: 18028022

2007
2007
Molecular mechanisms of autoimmunity.

Autoimmunity| PubMed ID: 18324481

2008
2008
2008
2008
Nature and functions of autoantibodies.

Nature clinical practice. Rheumatology| PubMed ID: 18756274

2008
2008
Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 19047283

2009
2008
2009
Response to sunitinib malate in advanced alveolar soft part sarcoma.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19188185

2009
Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors.

Molecular cancer therapeutics| PubMed ID: 19190116

2009
2009
Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 19273692

2009
2009
2009
2009
2009
Translocation-related sarcomas.

Seminars in oncology| PubMed ID: 19664492

2009
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 19723647

2009
2010
2009
2010
2010
2010
2010
2010
2010
2010
2011
Trabectedin therapy for sarcomas.

Current opinion in oncology| PubMed ID: 20489618

2010
2010
PML down-regulation in soft tissue sarcomas.

Journal of cellular physiology| PubMed ID: 20578240

2010
2010
2010
Novel models of myxoid liposarcoma xenografts mimicking the biological and pharmacologic features of human tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 20732964

2010
2010
2010
2010
2011
2011
2011
2011
2011
2010
Systemic therapy options for unresectable and metastatic chordomas.

Current oncology reports| PubMed ID: 21584646

2011
2011
2012
2012
2011
Uterine sarcomas: a multidisciplinary challenge.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 21944001

2011
2011
Rare cancers are not so rare: the rare cancer burden in Europe.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 22033323

2011
2012
2012
Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 22312103

2012
Phase II study of imatinib in advanced chordoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 22331945

2012
2012
2012
2012
2012
2012
B cell TLRs and induction of immunoglobulin class-switch DNA recombination.

Frontiers in bioscience (Landmark edition)| PubMed ID: 22652800

2012
2012
Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 22718859

2012
2012
Adjuvant therapy of gastrointestinal stromal tumors (GIST).

Current treatment options in oncology| PubMed ID: 22743760

2012
A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 22749255

2012
Evicase: an evidence-based case structuring approach for personalized healthcare.

Studies in health technology and informatics| PubMed ID: 22874262

2012
2012
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib.

Clinical sarcoma research| PubMed ID: 23058004

2012
2013
2012
2013
2013
Regulation of Aicda expression and AID activity.

Autoimmunity| PubMed ID: 23181381

2013
2013
Improving methodology to go beyond histology in rare cancers.

The Lancet. Oncology| PubMed ID: 23477834

2013
2013
2013
The intriguing patterns of tumor response to trabectedin.

Expert review of anticancer therapy| PubMed ID: 23638727

2013
Epigenetics of the antibody response.

Trends in immunology| PubMed ID: 23643790

2013
2013
Myxoid liposarcoma and the mammalian target of rapamycin pathway.

Current opinion in oncology| PubMed ID: 23673410

2013
Localised thoracic sarcomas: outcome improvement over time at a single institution.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 23683891

2013
2013
Adjuvant therapy for high-risk soft tissue sarcoma in the adult.

Current treatment options in oncology| PubMed ID: 23775297

2013
2013
2014
Targeted therapies in rare sarcomas: IMT, ASPS, SFT, PEComa, and CCS.

Hematology/oncology clinics of North America| PubMed ID: 24093175

2013
2014
2013
TSPAN33 is a novel marker of activated and malignant B cells.

Clinical immunology (Orlando, Fla.)| PubMed ID: 24211713

2013
2013
2014
Policy statement on multidisciplinary cancer care.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 24321260

2014
2013
2014
Emerging therapies for adult soft tissue sarcoma.

Expert review of anticancer therapy| PubMed ID: 24555529

2014
2014
MicroRNAs in lupus.

Autoimmunity| PubMed ID: 24826805

2014
2014
2014
2014
2015
2015
2014
2015
2015
2015
2015
2014
2015
2015
2015
2015
2015
2015
2015
Adjuvant chemotherapy for soft tissue sarcoma.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting| PubMed ID: 25993233

2015
2015
2015
Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

Clinical cancer research : an official journal of the American Association for Cancer Research| PubMed ID: 26261104

2016
Understanding Deviations from Clinical Practice Guidelines in Adult Soft Tissue Sarcoma.

Studies in health technology and informatics| PubMed ID: 26262055

2015
Imatinib in advanced chordoma: A retrospective case series analysis.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 26283036

2015
2015
2016
2015
2015
Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 26602014

2015
Adjuvant Imatinib for GI Stromal Tumors: When and For How Long?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology| PubMed ID: 26644523

2016
2015
2015
2016
Editorial: Epigenetics of B Cells and Antibody Responses.

Frontiers in immunology| PubMed ID: 26793194

2015
2016
2016
2016
2016
Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology| PubMed ID: 27330421

2016
2016
2016
2016
2017
2016
2016
2016
2017
2016
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair.

European journal of cancer (Oxford, England : 1990)| PubMed ID: 27866094

2017
Advances and controversies in the management of soft tissue sarcomas.

Future oncology (London, England)| PubMed ID: 27918199

2017
2017
2017
2017
2017
2016
2017
2017
2017
2017
Improving treatment results with reference centres for rare cancers: where do we stand?

European journal of cancer (Oxford, England : 1990)| PubMed ID: 28384534

2017
2017
2017
Neoadjuvant treatment: a novel standard?

Current opinion in oncology| PubMed ID: 28426465

2017
2017
2017
Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high-grade lesions.

Journal of magnetic resonance imaging : JMRI| PubMed ID: 28653477

2017
2017
2017
2016
2017